Ayse Akman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayse Akman has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Erkan Alpsoy
Department of Dermatology and Venereology Akdeniz University School of Medicine Antalya Turkey
18 shared publications - Ertan Yilmaz
Department of Dermatology and Venereology, Akdeniz University School of Medicine, Antalya, Turkey
5 shared publications Erkan Alpsoy
4 shared publications- Soner Uzun
Akdeniz University Department of Dermatology and Venereology, Faculty of Medicine Antalya
4 shared publications Hasan Kacaroglu
3 shared publications- Levent Donmez
Department of Public Health, Akdeniz University Faculty of Medicine, Antalya, Turkey
3 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Elsevier in SSRN Electronic Journal
Agent-Dependent Particulate Fragmentation of Autologous Biofiller Material: An In Vitro Study
Background:Biofillers are autologous, biocompatible dermal filler materials derived from platelet-poor plasma. However, there is no standardized strategy for managing potential complications associated with biofiller applications.Objective:This study aimed to evaluate the direct in vitro interaction between biofiller material and different dissolving agents and to compare their effects on biofiller particle fragmentation.Methods:Biofiller material (250 µL) was mixed with an equal volume of protease, saline, alteplase, collagenase, or hyaluronidase, respectively. The mixtures were vortexed to simulate the mechanical effect. Samples were imaged under a stereomicroscope, and particle counts were quantitatively analyzed using ImageJ software.Results:The highest mean particle count was observed in the biofiller + protease group, followed by the saline and collagenase groups. There was less particle fragmentation in the hyaluronidase and alteplase groups.Conclusion:Our study shows that the biofiller material demonstrates agent-dependent structural alterations in vitro. Protease exhibited the most pronounced degradative effect. The findings provide valuable information on the interactions between biofillers and agents. They could also serve as a basis for further experimental and translational studies.
- 27 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAgent-Dependent Particulate Fragmentation of Autologous Biofiller Material: An In Vitro Study
Background:Biofillers are autologous, biocompatible dermal filler materials derived from platelet-poor plasma. However, there is no standardized strategy for managing potential complications associated with biofiller applications.Objective:This study aimed to evaluate the direct in vitro interaction between biofiller material and different dissolving agents and to compare their effects on biofiller particle fragmentation.Methods:Biofiller material (250 µL) was mixed with an equal volume of protease, saline, alteplase, collagenase, or hyaluronidase, respectively. The mixtures were vortexed to simulate the mechanical effect. Samples were imaged under a stereomicroscope, and particle counts were quantitatively analyzed using ImageJ software.Results:The highest mean particle count was observed in the biofiller + protease group, followed by the saline and collagenase groups. There was less particle fragmentation in the hyaluronidase and alteplase groups.Conclusion:Our study shows that the biofiller material demonstrates agent-dependent structural alterations in vitro. Protease exhibited the most pronounced degradative effect. The findings provide valuable information on the interactions between biofillers and agents. They could also serve as a basis for further experimental and translational studies.
- Open Access
- 11 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5370
The Efficacy and Safety of CollaSel Pro® Hydrolyzed Collagen Peptide Supplementation without Addons in Improving Skin Health in Adult Females: A Double Blind, Randomized, Placebo-Controlled Clinical Study Using Biophysical and Skin Imaging Techniques
Background: This study aimed to evaluate the efficacy and safety of oral hydrolyzed collagen peptide (HCP) in healthy females by assessing the skin parameters via biophysical and skin imaging techniques. Methods: 112 females were randomly assigned to receive either HCP (n = 57; 10 g CollaSel Pro®) or placebo (n = 55; 10 g maltodextrin) daily for eight weeks. The contribution of HCP to skin elasticity, hydration, and roughness was investigated against a placebo, while the facial soft tissue sagging (RMS) and safety data were also recorded. Results: HCP was associated with significant improvements in skin elasticity (p = 0.009), skin hydration (p ranged from 0.003 to p ranged from 0.002 to p = 0.017), skin hydration (65.8 (18.9) vs. 53.1 (14.9) g/m3, p < 0.001) and skin roughness (40.2 (20.4) vs. 24.9 (20.9) g/m3, p < 0.001) were significantly higher. In the HCP group, week 8 RMS values were significantly lower than baseline values (1.02 (0.21) vs. 1.10 (0.21) mm, p = 0.012). Conclusions: CollaSel Pro® HCP can be considered a well-tolerated, safe product that effectively improves dermal health and the appearance of sagging and ameliorates the signs of the aging process.
- 11 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5370
Open AccessThe Efficacy and Safety of CollaSel Pro® Hydrolyzed Collagen Peptide Supplementation without Addons in Improving Skin Health in Adult Females: A Double Blind, Randomized, Placebo-Controlled Clinical Study Using Biophysical and Skin Imaging Techniques
Background: This study aimed to evaluate the efficacy and safety of oral hydrolyzed collagen peptide (HCP) in healthy females by assessing the skin parameters via biophysical and skin imaging techniques. Methods: 112 females were randomly assigned to receive either HCP (n = 57; 10 g CollaSel Pro®) or placebo (n = 55; 10 g maltodextrin) daily for eight weeks. The contribution of HCP to skin elasticity, hydration, and roughness was investigated against a placebo, while the facial soft tissue sagging (RMS) and safety data were also recorded. Results: HCP was associated with significant improvements in skin elasticity (p = 0.009), skin hydration (p ranged from 0.003 to p ranged from 0.002 to p = 0.017), skin hydration (65.8 (18.9) vs. 53.1 (14.9) g/m3, p < 0.001) and skin roughness (40.2 (20.4) vs. 24.9 (20.9) g/m3, p < 0.001) were significantly higher. In the HCP group, week 8 RMS values were significantly lower than baseline values (1.02 (0.21) vs. 1.10 (0.21) mm, p = 0.012). Conclusions: CollaSel Pro® HCP can be considered a well-tolerated, safe product that effectively improves dermal health and the appearance of sagging and ameliorates the signs of the aging process.
- 18 June 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (3) , E262-E265
Internalized stigma in chronic urticaria: A case–control study
- 18 June 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (3) , E262-E265
Internalized stigma in chronic urticaria: A case–control study
- 31 December 2020
- Published by Cumhuriyet University in Cumhuriyet Dental Journal
- Vol. 23 (4) , 325-330
CLINICAL ANALYSIS OF DESQUAMATIVE GINGIVITIS RELATED ORAL MUCOCUTANEOUS DISEASES
Objectives: Several mucocutaneous diseases are responsible for desquamative gingivitis (DG) and diagnostic delays are common in these diseases due to non-specific clinical oral presentations. The present study aimed to analyze the clinical features of DG-related mucocutaneous diseases with oral manifestations and compare the findings with previous reports. Materials and Methods: Thirty newly diagnosed patients with oral mucocutaneous disease in the Dermatology and Venereology Department of Akdeniz University Medical School, between January 2018 and January 2020, and referred to the Periodontology Department for periodontal treatment were evaluated retrospectively. Patients demographic data (age and gender), medical comorbidities, primary lesion site (oral or skin), and clinical features of gingival and oral lesions (location and symptoms) were examined. Results: There were 18 oral lichen planus (OLP), 8 pemphigus vulgaris (PV), and 4 mucous membrane pemphigoid (MMP) patients with oral involvements. The mean age of the patients was 50.03 ± 9.71 years with a female predominance (male to female ratio 1:1.7). All patients suffered from chronic burning sensation and oral pain. DG was detected in all three mucocutaneous diseases but OLP was the main disease associated with DG (60%). However other oral mucosal lesions and extraoral involvements were more frequent in PV patients. Conclusions: According to these results, OLP, MMP, and PV are the mucocutaneous diseases responsible for DG, and OLP is the most common cause of DG. Clinicans should be familiar with the clinical presentations and signs (patient complaints) of DG-related mucocutaneous disease for early diagnosis, proper treatment, and quality of life of the patient.
- 31 December 2020
- Published by Cumhuriyet University in Cumhuriyet Dental Journal
- Vol. 23 (4) , 325-330
CLINICAL ANALYSIS OF DESQUAMATIVE GINGIVITIS RELATED ORAL MUCOCUTANEOUS DISEASES
Objectives: Several mucocutaneous diseases are responsible for desquamative gingivitis (DG) and diagnostic delays are common in these diseases due to non-specific clinical oral presentations. The present study aimed to analyze the clinical features of DG-related mucocutaneous diseases with oral manifestations and compare the findings with previous reports. Materials and Methods: Thirty newly diagnosed patients with oral mucocutaneous disease in the Dermatology and Venereology Department of Akdeniz University Medical School, between January 2018 and January 2020, and referred to the Periodontology Department for periodontal treatment were evaluated retrospectively. Patients demographic data (age and gender), medical comorbidities, primary lesion site (oral or skin), and clinical features of gingival and oral lesions (location and symptoms) were examined. Results: There were 18 oral lichen planus (OLP), 8 pemphigus vulgaris (PV), and 4 mucous membrane pemphigoid (MMP) patients with oral involvements. The mean age of the patients was 50.03 ± 9.71 years with a female predominance (male to female ratio 1:1.7). All patients suffered from chronic burning sensation and oral pain. DG was detected in all three mucocutaneous diseases but OLP was the main disease associated with DG (60%). However other oral mucosal lesions and extraoral involvements were more frequent in PV patients. Conclusions: According to these results, OLP, MMP, and PV are the mucocutaneous diseases responsible for DG, and OLP is the most common cause of DG. Clinicans should be familiar with the clinical presentations and signs (patient complaints) of DG-related mucocutaneous disease for early diagnosis, proper treatment, and quality of life of the patient.
- Open Access
- 28 February 2019
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 57 (1) , 63-65
Laugier-Hunziker syndrome in a patient with rheumatoid arthritis
Laugier-Hunziker syndrome is a rare benign idiopathic condition characterized by acquired macular pigmentation of the lips and buccal mucosa, often accompanied by melanonychia. Although the etiopathogenesis is not fully known, tyrosine is thought to be responsible for the pathogenesis of enzyme hyperactivity in melanin biosynthesis. We present the case of a 66-year-old woman diagnosed with Laugier-Hunziker syndrome and rheumatoid arthritis.
- 28 February 2019
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 57 (1) , 63-65
Open AccessLaugier-Hunziker syndrome in a patient with rheumatoid arthritis
Laugier-Hunziker syndrome is a rare benign idiopathic condition characterized by acquired macular pigmentation of the lips and buccal mucosa, often accompanied by melanonychia. Although the etiopathogenesis is not fully known, tyrosine is thought to be responsible for the pathogenesis of enzyme hyperactivity in melanin biosynthesis. We present the case of a 66-year-old woman diagnosed with Laugier-Hunziker syndrome and rheumatoid arthritis.
- 2 June 2018
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (1) , E5-E7
A rare case with prominent features of both discoid lupus erythematosus and pemphigus foliaceus
- 2 June 2018
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (1) , E5-E7
A rare case with prominent features of both discoid lupus erythematosus and pemphigus foliaceus
- Open Access
- 2 April 2018
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 12 (1) , 33-37
Defining the Natural Course of Psoriasis: A Single-Center Cohort Study of 100 Patients
- 2 April 2018
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 12 (1) , 33-37
Open AccessDefining the Natural Course of Psoriasis: A Single-Center Cohort Study of 100 Patients
- Open Access
- 29 October 2016
- Published by Gavin Publishers in Dentistry: Advanced Research
- Vol. 2 (3)
Relationship Between Periodontal Findings and Oral Lichen Planus: A Controlled Study
Objective: The aim of this study was to evaluate the periodontal status of oral lichen planus patients and compare them with healthy controls. We also investigated the relationship between the periodontal condition and clinical activity in patients. Materials and Methods: Twenty five patients (16 women, 9 men; 47.5±10.2 years) with oral Lichen Planus (LP), twenty five healthy subjects (13 women, 12 men; 43.4±8.3 years) were included in the study. The periodontal status of all subjects was evaluated according to CPITN. Patients were also assessed for clinical activity by REU scoring system. Results: The mean CPITN was statistically significantly higher in patients (2.2±0,9) compared to healthy controls (1.3±0.9) (p=0.001). Age (p=0.027), having Oral LP (p=0.006) were found to be significant risk factors for higher CPITN. The higher CPITN was found to be a significant risk factor for the development of LP (p=0.006). Severe CPITN was found to be a significant risk factor for higher REU (p=0.041). Conclusions: Oral LP could affect the development of the periodontal disease. Severe periodontitis could be a risk factor not only for the development or progression of lichen planus but also Oral LP. Patients should be encouraged long-term periodontal follow-up by dental professionals. Keywords: Oral lichen planus; Periodontitis; Disease severity
- 29 October 2016
- Published by Gavin Publishers in Dentistry: Advanced Research
- Vol. 2 (3)
Open AccessRelationship Between Periodontal Findings and Oral Lichen Planus: A Controlled Study
Objective: The aim of this study was to evaluate the periodontal status of oral lichen planus patients and compare them with healthy controls. We also investigated the relationship between the periodontal condition and clinical activity in patients. Materials and Methods: Twenty five patients (16 women, 9 men; 47.5±10.2 years) with oral Lichen Planus (LP), twenty five healthy subjects (13 women, 12 men; 43.4±8.3 years) were included in the study. The periodontal status of all subjects was evaluated according to CPITN. Patients were also assessed for clinical activity by REU scoring system. Results: The mean CPITN was statistically significantly higher in patients (2.2±0,9) compared to healthy controls (1.3±0.9) (p=0.001). Age (p=0.027), having Oral LP (p=0.006) were found to be significant risk factors for higher CPITN. The higher CPITN was found to be a significant risk factor for the development of LP (p=0.006). Severe CPITN was found to be a significant risk factor for higher REU (p=0.041). Conclusions: Oral LP could affect the development of the periodontal disease. Severe periodontitis could be a risk factor not only for the development or progression of lichen planus but also Oral LP. Patients should be encouraged long-term periodontal follow-up by dental professionals. Keywords: Oral lichen planus; Periodontitis; Disease severity
- 22 September 2016
- Published by Wiley in International Journal of Dermatology
- Vol. 55 (12) , 1362-1368
Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey
Pemphigus vulgaris (PV) is a severe, chronic, and potentially life-threatening autoimmune blistering disease that affects the skin and mucous membranes. Rituximab is a monoclonal anti-CD20 antibody which has been used increasingly in the therapy of PV. The present study sought to test the efficacy and safety of rituximab as an adjuvant therapy by retrospective analysis of clinical and immunological data for 29 patients with PV who were treated with rituximab between 2010 and 2015. Response to therapy, duration of clinical remission, serology of the response, and adverse effects of rituximab were evaluated. The mean ± standard deviation (SD) follow-up time was 17.48 ± 13.18 months. In all patients, findings showed either a decrease in antibody titers or that antibodies were completely undetectable after therapy. Rituximab use resulted in a significant reduction in steroid dosage during follow-up. At the end of the follow-up period, 26 patients (96.2%) had achieved complete remission with or without therapy (one patient had no follow-up and one patient had died, most probably as the result of a thromboembolic event). In 44.4% of patients, a clinical relapse occurred after a mean ± SD period of 13.1 ± 4.7 months after the initiation of rituximab therapy. Relapses were managed with additional infusions of rituximab. Rituximab is a beneficial and relatively safe adjuvant treatment for PV that facilitates prolonged clinical remission and has a significant steroid-sparing effect.
- 22 September 2016
- Published by Wiley in International Journal of Dermatology
- Vol. 55 (12) , 1362-1368
Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey
Pemphigus vulgaris (PV) is a severe, chronic, and potentially life-threatening autoimmune blistering disease that affects the skin and mucous membranes. Rituximab is a monoclonal anti-CD20 antibody which has been used increasingly in the therapy of PV. The present study sought to test the efficacy and safety of rituximab as an adjuvant therapy by retrospective analysis of clinical and immunological data for 29 patients with PV who were treated with rituximab between 2010 and 2015. Response to therapy, duration of clinical remission, serology of the response, and adverse effects of rituximab were evaluated. The mean ± standard deviation (SD) follow-up time was 17.48 ± 13.18 months. In all patients, findings showed either a decrease in antibody titers or that antibodies were completely undetectable after therapy. Rituximab use resulted in a significant reduction in steroid dosage during follow-up. At the end of the follow-up period, 26 patients (96.2%) had achieved complete remission with or without therapy (one patient had no follow-up and one patient had died, most probably as the result of a thromboembolic event). In 44.4% of patients, a clinical relapse occurred after a mean ± SD period of 13.1 ± 4.7 months after the initiation of rituximab therapy. Relapses were managed with additional infusions of rituximab. Rituximab is a beneficial and relatively safe adjuvant treatment for PV that facilitates prolonged clinical remission and has a significant steroid-sparing effect.
- Open Access
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (5) , 790-794
Is There an Association between Restless Legs Syndrome and Urticaria?
Tuna S, et al. J Korean Med Sci. 2016 May;31(5):790-794. https://doi.org/10.3346/jkms.2016.31.5.790
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (5) , 790-794
Open AccessIs There an Association between Restless Legs Syndrome and Urticaria?
Tuna S, et al. J Korean Med Sci. 2016 May;31(5):790-794. https://doi.org/10.3346/jkms.2016.31.5.790